XM does not provide services to residents of the United States of America.

W
W

Waters

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Reuters - 3 weeks ago

S&P 500 top and bottom performing stocks at about 12:00 p.m. EST

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST S&P 500 .SPX Top Performers Percent Change Agilent Technologies Inc A.N +8.9% Mettler-Toledo International Inc MTD.N +6.7% Waters Corp WAT.N +6.3% Danaher Corp DHR.N +4.5% Thermo Fisher Scientific Inc TMO.N +4.3% Bottom Performers Percent Change Jacobs Solutions Inc J.N -8.1% V
A
C
U
T
W
J
L
M
Reuters - 3 weeks ago

U.S. STOCKS Dycom Industries, Crypto stocks, Burlington Stores

BUZZ-U.S. STOCKS ON THE MOVE-Dycom Industries, Crypto stocks, Burlington Stores Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks fell on Tuesday as investors awaited Nvidia's quarterly results and the Federal Reserve's policy meeting minutes, while multiple downbeat earnings from retailers also weighed on sentiment.
A
B
C
C
C
N
Z
U
U
U
W
X
C
M
Reuters - 1 month ago

Waters Corp gains on Q3 profit beat

BUZZ-Waters Corp gains on Q3 profit beat ** Lab equipment maker Waters Corp's WAT.N shares up 2.1% at $257.32 ** Company posts Q3 adj profit of $2.84/shr vs est $2.55/shr - LSEG data ** Q3 sales of $711.7 mln vs $708.6 mln a year earlier ** Company's results helped by lower operation expenses and strong demand in the U.S. and European markets for p
W
Reuters - 1 month ago

Waters Corp reports results for the quarter ended in September - Earnings Summary

Waters Corp reports results for the quarter ended in September - Earnings Summary Waters Corp WAT.N reported quarterly adjusted earnings of $2.84​​ per share for the quarter ended in September, higher than the same quarter last year, when the company reported EPS of $2.64. The mean expectation of seventeen analysts for the quarter was for earnings of $2.55 per share.
W
Reuters - 1 month ago

Waters Corp cuts 2023 profit forecast as biotech funding crunch persists

Waters Corp cuts 2023 profit forecast as biotech funding crunch persists Nov 7 (Reuters) - Lab equipment and software maker Waters Corp WAT.N on Tuesday cut its annual profit forecast for the second time in a year as demand for its products continued to weaken over a funding crunch among its biopharma clients, especially in China. Biotechs have seen reduced drug development budgets since the start of the year over higher borrowing costs.
T
W

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.